Vistagen Therapeutics, Inc. (VTGN)
0.6188
+0.02
(+3.84%)
USD |
NASDAQ |
Apr 30, 16:00
0.6188
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap : 24.52M for April 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alector, Inc. | 261.56M |
| ACADIA Pharmaceuticals, Inc. | 3.828B |
| Alnylam Pharmaceuticals, Inc. | 41.01B |
| Savara, Inc. | 1.070B |
| BioMarin Pharmaceutical, Inc. | 10.37B |
Market Cap Related Metrics
| PS Ratio | 20.94 |
| PEG Ratio | -0.0075 |
| Price to Book Value | 0.4815 |
| Price | 0.6188 |
| Earnings Yield | -310.6% |
| PEGY Ratio | -0.0075 |